Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Prospective Study With Benralizumab to Investigate Clinical Outcome Based on Standard of Care Medication in Real-life

NCT06422078 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06422078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06422078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Prospective Study With Benralizumab to Investigate Clinical Outcome Based on Standard of Care Medication in Real-life
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
July 25, 2024
Completion date
December 31, 2027
Enrollment
300 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, bronchial